Knopp Biosciences’ investigational, first-in-class drug, dexpramipexole, holds promise for patients with asthma and eosinophil-associated diseases.

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as many updated charts and tools.

The human body has three primary lines of defense to fight against foreign invaders, including viruses, bacteria, and fungi.

Type 2 inflammation is an immune response designed to protect the body against parasites. But it can sometimes overreact and lead to a number of conditions, such as asthma, atopic dermatitis, and ...

Use of Granulocyte Colony-stimulating Factor in Patients with Severe Sepsis or Septic Shock Rima A. Mohammad Disclosures Am J Health Syst Pharm. 2010;67 (15):1238-1245.